Abiopharma

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

4DMT to Participate in Jefferies 2025 London Healthcare Conference

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development

Allurion - Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

TruBridge, Inc.: TruBridge Announces Third Quarter 2025 Results

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Tandem Diabetes Care Announces Third Quarter 2025 Financial Results

Astrana Health, Inc. Reports Third Quarter 2025 Results

Natera - Natera Reports Third Quarter 2025 Financial Results